Q3 2023 Oncolytics Biotech Inc Earnings Call Transcript
Good morning, and welcome to Oncolytics Biotech's third-quarter 2023 conference call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.
I would now like to turn the call over to Jon Patton, Director of Investor Relations and Communication.
Thank you, operator. And good morning, everyone. Earlier this morning, Oncolytics issued a press release providing recent operational highlights and financial results for the third quarter of 2023. A replay of today's call will be available on the events section of the Oncolytics website approximately two hours after its completion. After remarks from company management, we will open the call for Q&A.
As a reminder, various remarks made during this call contain certain forward looking statements relating to the company's business prospects, and the development, and commercialization of pelareorep, including statements regarding the company's mission, strategy, and objectives,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
